InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,890.40
(
-1.00%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.26
(
0.04%
)
Bitcoin
63,702.90
(
-0.90%
)
Post# of 1434
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

rikic

Send PM Follow Ignore
Followers 2
Posts 298
Boards Moderated 0
Alias Born 08/16/2010

rikic

Re: None

Thursday, 11/30/2017 10:27:13 AM

Thursday, November 30, 2017 10:27:13 AM

Post# of 1434
The FDA's Antimicrobial Drugs Advisory Committee will meet on Thursday, January 11 to discuss Aradigm's New Drug Application (NDA) seeking approval for Linhaliq (ciprofloxacin) for the treatment of non-cystic fibrosis bronchiectasis in patients with chronic infections due to Pseudomonas aeruginosa.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up